# A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)

> **NCT00462748** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 786 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** ezetimibe (+) simvastatin
- **DRUG:** Comparator: atorvastatin
- **DRUG:** Comparator: rosuvastatin

## Key facts

- **NCT ID:** NCT00462748
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 786 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00462748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00462748, "A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00462748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*